Clinical Trial Update: Control of Asthma Patients Symptomatic on Inhaled Corticosteroids [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating control of asthma symptoms in patients on inhaled corticosteroids has completed. The sponsor is Inflazyme Pharmaceuticals Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Inflazyme investigational drug

Snippet

Sponsor: Inflazyme Pharmaceuticals Ltd | Conditions: Asthma | Phase 2 | Status: COMPLETED